Clinical utility of circulating tumor DNA in patients with advanced KRAS G12C-mutated NSCLC treated with sotorasib

被引：0
|
作者：
Ernst, Sophie M.
van Marion, Ronald
Atmodimedjo, Peggy N.
de Jonge, Evert
Mathijssen, Ron H.
Paats, Marthe S.
de Bruijn, Peter
van Schaik, Ron H. N.
Dubbink, Hendrikus J.
Dingemans, Anne-Marie C.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2137
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
    Strickler, J. H.
    Satake, H.
    George, T. J.
    Yaeger, R.
    Hollebecque, A.
    Garrido-Laguna, I.
    Schuler, M.
    Burns, T. F.
    Coveler, A. L.
    Falchook, G. S.
    Vincent, M.
    Sunakawa, Y.
    Dahan, L.
    Bajor, D.
    Rha, S. -Y.
    Lemech, C.
    Juric, D.
    Rehn, M.
    Ngarmchamnanrith, G.
    Jafarinasabian, P.
    Tran, Q.
    Hong, D. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01): : 33 - 43
  • [22] Sotorasib for KRAS p.G12C-mutated advanced pancreatic cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 213 - 213
  • [23] Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib
    Skoulidis, F.
    Schuler, M.
    Wolf, J.
    Barlesi, F.
    Price, T.
    Dy, G.
    Govindan, R.
    Borghaei, H.
    Falchook, G.
    Li, B.
    Ramalingam, S.
    Sacher, A.
    Spira, A.
    Takahashi, T.
    Anderson, A.
    Ang, A.
    Dai, T.
    Flesher, D.
    Cifuentes, P.
    Velcheti, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S929 - S930
  • [24] Use of sotorasib in KRAS p. G12C mutated NSCLC: a case report
    Barot, Hasti
    Evans, Joanne
    Mohammed, Waleed
    Power, Danielle
    LUNG CANCER, 2022, 165 : S77 - S77
  • [25] Patient-reported outcomes from the CodeBreaK 200 phase III trial comparing sotorasib versus docetaxel in KRAS G12C-mutated NSCLC
    Waterhouse, D. M.
    Rothschild, S.
    Dooms, C.
    Mennecier, B.
    Bozorgmehr, F.
    Majem, M.
    van den Heuvel, M.
    Linardou, H.
    Chul-Cho, B.
    Roberts-Thomson, R.
    Okamoto, I.
    Blais, N.
    Schvartsman, G.
    Holmskov, K.
    Chmielewska, I.
    Forster, M.
    Stollenwerk, B.
    Obiozor, C. C.
    Wang, Y.
    Novello, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S37 - S38
  • [26] Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary
    de Langen, Adrianus Johannes
    Johnson, Melissa L.
    Mazieres, Julien
    Dingemans, Anne-Marie C.
    Mountzios, Giannis
    Pless, Miklos
    Wolf, Juergen
    Schuler, Martin
    Lena, Herve
    Skoulidis, Ferdinandos
    Yoneshima, Yasuto
    Kim, Sang-We
    Linardou, Helena
    Novello, Silvia
    van der Wekken, Anthonie J.
    Chen, Yuanbin
    Peters, Solange
    Felip, Enriqueta
    Solomon, Benjamin J.
    Ramalingam, Suresh S.
    Dooms, Christophe
    Lindsay, Colin R.
    Ferreira, Carlos Gil
    Blais, Normand
    Obiozor, Cynthia C.
    Wang, Yang
    Mehta, Bhakti
    Varrieur, Tracy
    Ngarmchamnanrith, Gataree
    Stollenwerk, Bjoern
    Waterhouse, David
    Paz-Ares, Luis
    FUTURE ONCOLOGY, 2025,
  • [27] Sotorasib as First-Line Treatment for Advanced KRAS G12C-Mutated Non-Small Cell Lung Carcinoma: A Case Report
    Iska, Sindu
    Alley, Evan W.
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 183 - 187
  • [28] KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen
    Ciner, Aaron
    Ardalan, Bach
    Baca, Yasmine
    Darabi, Sourat
    Kasi, Anup
    Lou, Emil
    Azqueta, Jose Ignacio
    Xiu, Joanne
    Nabhan, Chadi
    Shields, Anthony F.
    Aguirre, Andrew
    Singh, Harshabad
    Shroff, Rachna T.
    Pishvaian, Michael J.
    Goel, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Durability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor
    Hong, D. S.
    Bang, Y. -J.
    Barlesi, F.
    Durm, G.
    Falchook, G.
    Govindan, R.
    Dy, G.
    Park, K.
    Strickler, J.
    Burns, T.
    Kim, J.
    Ang, A.
    Lipford, J. R.
    Ngarmchamnanrith, G.
    Anderson, A.
    Li, B. T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S28 - S29
  • [30] Sotorasib with panitumumab in chemotherapy-refractory KRAS G12C-mutated colorectal cancer: a phase 1b trial
    Kuboki Y.
    Fakih M.
    Strickler J.
    Yaeger R.
    Masuishi T.
    Kim E.J.
    Bestvina C.M.
    Kopetz S.
    Falchook G.S.
    Langer C.
    Krauss J.
    Puri S.
    Cardona P.
    Chan E.
    Varrieur T.
    Mukundan L.
    Anderson A.
    Tran Q.
    Hong D.S.
    Nature Medicine, 2024, 30 (1) : 265 - 270
12345